Exscientia

Acquired

Pioneering AI Drug Discovery | Recursion

Oxford, United Kingdom · Founded 2012 · $351.0M raised

Headquarters
Oxford
Employees
201–500
Founded
2012
Business Model
B2B
Total Funding
$351.0M
Last Round
$225.0M Series DApr 2021
Rounds
4
Acquired by
RecursionAug 2024 · $688.0M

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Exscientia was an Oxford-based AI-driven pharmatech company pioneering the automation of drug discovery and design. Founded in 2012, it was the first company to advance AI-designed drug molecules into human clinical trials. Exscientia was acquired by Recursion Pharmaceuticals in 2024 for approximately $688 million.

Summary

Exscientia is an Artificial Intelligence company based in Oxford, United Kingdom, founded in 2012. It has raised $351.0M in total across 4 rounds, most recently a $225.0M Series D round in Apr 2021. Investors include GT Healthcare Capital, Novo Holdings A/S and Recursion Pharmaceuticals.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionAug 2024

Sign up to see all 6 events

Funding: Series B through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series FTotal funding$3.8BJan 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Exscientia on Indexed.vc
<a href="https://indexed.vc/companies/exscientia"><img src="https://indexed.vc/api/badge/company/exscientia" alt="Exscientia on Indexed.vc" width="260" height="76" /></a>